Literature DB >> 25320041

Maternal cardiac function, uteroplacental Doppler flow parameters and pregnancy outcome: a systematic review.

M A M Kampman1,2, C M Bilardo3, B J M Mulder4, J G Aarnoudse3, C Ris-Stalpers5,6, D J van Veldhuisen1, P G Pieper1.   

Abstract

OBJECTIVE: To investigate the existing evidence for a link between maternal cardiac function, abnormal uteroplacental flow and poor perinatal outcome in women with and without known cardiac disease.
METHODS: PubMed and EMBASE databases were searched systematically for studies relating cardiac functional parameters and uteroplacental Doppler flow with pregnancy outcome in women with pre-existing congenital cardiac disease and women without known cardiac disease. Only studies based on echocardiography were included.
RESULTS: From 1732 citations, 10 articles were included. In women with known congenital heart disease, a relationship was found between abnormal uteroplacental Doppler flow patterns and cardiac function before and during pregnancy. Conversely, women without a history of congenital heart disease, but with abnormal uterine artery resistance and pregnancy complications, more often showed global left ventricular diastolic dysfunction (33%; P = 0.0001), impaired myocardial relaxation (72%; P < 0.0001) and left ventricular systolic dysfunction (17%; P = 0.006), even up to 1 year postpartum.
CONCLUSION: There is increasing evidence for an association between pre-existing subclinical cardiac dysfunction, poor placentation (reflected by uteroplacental Doppler flow abnormalities) and poor pregnancy outcome. It may be postulated that pre-existing suboptimal cardiac performance, as a result of either congenital heart disease or a subclinical latent condition, is one of the common denominators of poor placentation, leading to poor pregnancy outcome.
Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  congenital heart disease; maternal cardiac function; pregnancy; uteroplacental Doppler flow

Mesh:

Year:  2015        PMID: 25320041     DOI: 10.1002/uog.14697

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  4 in total

Review 1.  Use of medication for cardiovascular disease during pregnancy.

Authors:  Petronella G Pieper
Journal:  Nat Rev Cardiol       Date:  2015-12       Impact factor: 32.419

2.  Maternal and fetal outcomes in pregnant females with rheumatic heart disease.

Authors:  Roopali Khanna; Deepti Chandra; Sangeeta Yadav; Ankit Sahu; Neeta Singh; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Aditya Kapoor; Mandakini Pradhan; Pravin K Goel
Journal:  Indian Heart J       Date:  2021-01-16

3.  Neonatal Risk in Children of Women With Congenital Heart Disease: A Cohort Study With Focus on Socioeconomic Status.

Authors:  Stine Kloster; Janne S Tolstrup; Morten Smærup Olsen; Søren Paaske Johnsen; Lars Søndergaard; Dorte Guldbrand Nielsen; Annette Kjær Ersbøll
Journal:  J Am Heart Assoc       Date:  2019-10-28       Impact factor: 5.501

4.  Pregnancy outcomes in women with Budd-Chiari syndrome or portal vein thrombosis - a multicentre retrospective cohort study.

Authors:  Hmg Wiegers; E N Hamulyák; S E Damhuis; J R van Duuren; S Darwish Murad; Ljj Scheres; S J Gordijn; J Leentjens; J J Duvekot; M N Lauw; B A Hutten; S Middeldorp; W Ganzevoort
Journal:  BJOG       Date:  2021-10-04       Impact factor: 7.331

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.